Register for the FREE live event here: https://jhmi.co1.qualtrics.com/jfe/form/SV_blwcEmYRaPk9qVU
Register for the Annual Convention here: https://convention.apa.org/
Cecilia Bergeria
Division 28 Program Chair
2021-07-12
2021-07-10
[#DIV28SUPER] Behavior & Addiction Research Lab PhD Open House
Hello all,
Hope you are enjoying your summer! I am seeking applications for our PhD program in counseling psych at Southern Miss for 2022 (deadline 12-1-21). As part of recruiting for the lab I will be hosting a few virtual open houses about the lab, our research focus and discuss applying to PhD programs in general. The information is below as well as a link to register for the first open house. We will discuss the structure of the lab, focus of our work, potential future directions, alumni achievements, and the opportunity to ask questions or me and some students. Please pass this information to any undergrad or master’s degree students you work with who are considering PhD programs and may be interested in learning more. Advanced registration is required! Thanks. Have a good day. Mike
BAR Lab Info Session
When: Jul 28, 2021 01:00 PM Central Time (US and Canada)
Register in advance for this meeting:
https://usm-edu.zoom.us/meeting/register/tZ0kdOmrqzooG9Om_blI1_4xY98N-mwK7Frr
After registering, participants will receive a confirmation email containing information about joining the meeting.
Michael B. Madson, Ph.D.
Professor
School of Psychology
Associate Chair – USM Institutional Review Board
Undergraduate Program Coordinator
The University of Southern Mississippi
118 College Dr #5025
Hattiesburg, MS 39406
601-266-4546
Twitter: @UsmBar
Click on this link to unsubscribe from the DIV50DISCUSS list UNSUBSCRIBE
An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list.
2021-07-08
[#DIV28SUPER] job posting for clinical psychologist
The Cofrin Logan Center and Center for the Advancement of Research on Eating Behaviors at the University of Kansas are seeking a clinical psychologist.
Please see link for full position details and application.
Richard Yi, Ph.D.
Director, Cofrin Logan Center for Addiction Research and Treatment
Professor, Department of Psychology
University of Kansas, Lawrence, KS 66045
Email: ryi1@ku.edu Phone: 785-864-6476
2021-07-07
[#DIV28SUPER] post-doc position at Univ of Nebraska
Posted for Dr. Ken Wakabayashi. Please share widely...
Seeking Full-time Postdoctoral Researcher in Behavioral Neuroscience
The Neurocircuitry of Motivated Behavior (NMB) Laboratory at the University of Nebraska-Lincoln (PI: K.T. Wakabayashi, Ph.D. Please see https://psychology.unl.edu/ken-wakabayashi) invites applications for a full-time Postdoctoral Researcher in Behavioral Neuroscience. We are looking for an enthusiastic and motivated postdoctoral researcher to take a key role in planning and executing both behavioral and basic neuroscience experiments. The NMB laboratory studies brain circuits that regulate motivated behavior, particularly as they relate to natural, alcohol and drug reward and abuse.
Duties will include, planning and executing new experimental projects in the laboratory, direct oversight of ongoing experimental projects in the lab, management of undergraduate students, data analyses, and preparing manuscripts for publications and grants for funding. The term of employment is for 2 years, with a possible extension with satisfactory performance and availability of funding.
Responsibilities include planning and executing multiple experiments and projects, data analyses, writing manuscripts, assisting in grant application preparation, and supervising undergraduate students. Our behavioral assays include operant reward-seeking, intravenous drug self-administration, alcohol drinking models, and anxiety-related behaviors (elevated maze, marble burying). In addition, advanced neuroscience techniques including Designer Receptors Exclusively Activated by Designer Drugs (DREADDs), immunohistochemistry, enzyme-linked electrochemical biosensors and in vivo calcium imaging with fiber photometry are used to examine the neurocircuitry underlying these behaviors. Jugular catheterization and stereotaxic surgeries are performed on a regular basis.
The applicant will be expected to keep good records of experiments, results, etc.
Required Qualifications
- A Ph.D. and relevant research experience in neuroscience or related fields (e.g. Biological Psychology, Behavioral Neuroscience, Pharmacology).
- Highly organized and extremely reliable.
- Prior experience working with rats and conducting behavioral studies, and also have technical experience with rodent surgery (e.g. stereotaxic, catheterization).
- Proficient with Excel and basic Microsoft Office applications (Word, Powerpoint).
- Highly motivated, have established ability to communicate in English and have the ability to work effectively in a team environment.
- Excellent writing skills, including evidence of successful manuscript writing (first author publications) and publication productivity.
Preferred Qualifications
- Familiarity or experience with modern neuroscience techniques, such as DREADDs, optogenetics, calcium imaging, fiber photometry or other in vivo monitoring techniques, advanced immunohistochemistry, and operant behavior such as self-administration.
- Prior experience with programming languages (Med-State, MATLAB, Python).
Salary will be commensurate with prior experience.
Review of applications will begin July 26, 2021 and will continue until the position is filled or the search is closed. To apply, go to https://employment.unl.edu/postings/73026. Click "Apply for this Job" and complete the information form. Attach a letter of interest, including research background and career interests; a curriculum vitae; and a list of professional references.
As an EO/AA employer, qualified applicants are considered for employment without regard to race, color, ethnicity, national origin, sex, pregnancy, sexual orientation, gender identity, religion, disability, age, genetic information, veteran status, marital status, and/or political affiliation. See http://www.unl.edu/equity/notice-nondiscrimination.
2021-07-03
[#DIV28SUPER] Program Officer Position Openings in the Division of Neuroscience and Behavior (DNB) at the National Institute on Drug Abuse, NIH
Program Officer Position Openings in the Division of Neuroscience and Behavior (DNB) at the National Institute on Drug Abuse, NIH
Program Officer Opening in Chemistry:
NIDA’s Division of Neuroscience and Behavior is recruiting for a Program Officer position within the Chemistry Pharmacology Physiology (CPP) Branch. The Program Officer is expected to develop and oversee a grant portfolio in the rapidly growing field of chemistry and pharmacology of drugs of abuse. The Branch supports all research related to the chemistry and pharmacology of drugs of abuse including the structural dynamics of receptors, computationally-based drug design, intracellular signaling mechanisms, early drug discovery of treatments for addiction, natural product chemistry, and innovative mechanisms of drug delivery. Required areas of expertise includes chemistry, drug design, biophysical and computational approaches, biochemical and neurobiological mechanisms of substance use disorders.
Candidates interested in applying for this position should send a cover letter and curriculum vitae to Dr. Sam Ananthan via email at sam.ananthan@nih.gov
----------
Program Officer Opening in Behavior and Cognitive Neuroscience:
NIDA’s Division of Neuroscience and Behavior is recruiting for a Program Officer position within the Behavioral and Cognitive Neuroscience (BCN) Branch. The Program Officer is expected to oversee a portfolio covering neurocognitive mechanisms related to substance use disorder (SUD) and bidirectional translational research through human laboratory studies and animal models. In addition, the Program Officer is expected to participate in NIDA-wide and NIH-wide activities related to neurocognition and SUD. Required expertise includes:
• Neurocircuitry and cognition related to SUD
• Biostatistical approaches used to analyze large-scale datasets
• Advanced analysis methods for neuroimaging data
Please see the attached flyer for more details and email Dr. Vani Pariyadath (vani.pariyadath@nih.gov) if you’re interested in applying.
---------
Program Officer Position in Data Science:
The National Institute on Drug Abuse (NIDA), Division of Neuroscience and Behavior, Office of the Director is currently recruiting for a data science Program Officer. The mission of the Division of Neuroscience and Behavior is to discover, facilitate and promote outstanding basic animal and human research supporting the mission of NIDA, to identify the causes and consequences of drug addiction and misuse across the lifespan and to guide treatment strategies. DNB develops and supports an extramural research program that will advance the understanding of the genetic, chemical, neurobiological and behavioral mechanisms of drugs of abuse and their long-term consequences. Research related to the neurobiological bases of reward and the behaviors that characterize the cycle of addiction are a primary focus of DNB. Additionally, an integral component of DNB’s scientific mission is to grow and maintain a diverse workforce that is dedicated to these research goals and is supported through training initiatives that span from predoctoral level to mid-stage investigator. The Office of the Director directs, coordinates, and supports the Division’s missions and activities through maintaining and evaluating strategic directions and goals, supporting goals through the branch structure, and developing and leveraging collaborations and activities across NIDA and NIH.
The data science Program Officer would be responsible for assisting in the management of a research portfolio of grants using data science approaches to advance science on the causes of consequences of drug use and addiction. Additionally, the grant portfolio would include data curation, sharing, access, reproducibility, security, analysis, harmonization, quality metrics and standards, and visualization. The data science program officer would also serve as a representative for NIDA on NIH-wide and multi-agency committees.
The job listing will be posted soon. Please contact Susan Wright (susan.wright@nih.gov) and Roger Little (alittle@mail.nih.gov) for more information.
----------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L
2021-07-01
[#DIV28SUPER] Call for Editorial Fellow Applications: Experimental and Clinical Psychopharmacology
Experimental and Clinical Psychopharmacology announces an opening for an Editorial Fellow position, beginning January 1, 2022. The position is open to qualified candidates who hold the rank of Assistant Professor (or equivalent) and will last one year. During this time, the selected Fellow will work closely with the journal's Editor, Dr. William W. Stoops, to develop editorial and publishing proficiency, enrich scientific knowledge and bolster written communication skills. It is anticipated that the Fellow will manage approximately one new manuscript per month. This process will include identifying reviewers, making an editorial decision based on review and shepherding the manuscript through to publication if accepted, all with guidance from Dr. Stoops. The successful candidate will also be expected to participate in monthly meetings with Dr. Stoops to ensure goals are met and problems are identified and addressed. The majority of these meetings will be held virtually, although in-person meetings at scientific conferences are also possible. Upon successful completion of the fellowship, the Editorial Fellow will become a member of the journal's editorial board. All applications should include the following: 1) an interest statement, 2) a curriculum vitae and 3) three recommendation letters. Application materials are due to Dr. Stoops (william.stoops@uky.edu) on September 1, 2021 at 5 PM Eastern time and should be submitted as a single pdf file. Applications will be reviewed by members of the Experimental and Clinical Psychopharmacology editorial board for strength of the interest statement, research and publishing experience, manuscript review experience and enthusiasm of the recommendation letters. The top candidate will be notified of her/his selection by December 1, 2021. Address any questions to Dr. Stoops at william.stoops@uky.edu.
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383
Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky
Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science
Clinical Research Support Office
Associate Director for Clinical Research
Substance Use Priority Research Area
STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.
2021-06-28
Re: [#DIV28SUPER] In Memoriam: Dr. Martin Iguchi, Ph.D.
Thank you for sharing this news, Kelly. I am just now seeing it.
For those who did not get to know Martin personally, I strongly suggest looking him up on google scholar and reading the links below. You will find the breadth and depth of his work both inspiring and humbling. And as the words below convey, he was not only a stellar psychologist, but a stellar human being who was simply kind and encouraging to all who wanted to learn and help the world be a better place.
I really do consider him to be one of the trail blazing giants of our time in the field, particularly in terms of his impact on public health. I hope the division will consider someway to memorialize him and the work he was able to do.
I will miss him very much; he was an inspiration and amazing role model.
-Nancy
Nancy A. Piotrowski, Ph.D.
Council Representative, Society of Environmental, Population, & Conservation Psychology, Division 34, American Psychological AssociationTreasurer/Past President/LAN Chair, Napa Solano Psychological Association
Trustee, California Psychological Association PAC
Commissioner, National Certification Commission for Addiction Professionals
MAIL: P.O. Box 5525, Vallejo, California 94591-0552
With Offices in the San Francisco Bay Area
Office Phone: 707.561.2358
FAX by request
Office Phone: 707.561.2358
FAX by request
ALT Email: PiotrowskiConsultation@gmail.com
Skype: napiotrowski
IMPORTANT NOTICE: This transmission and any attachments are intended only for the individual or entity to which it is addressed and may contain information that is privileged, confidential or exempt from disclosure under applicable federal or state laws. If the reader of this transmission is not the intended recipient, you are hereby notified that any use, dissemination, distribution or copying of this communication, without explicit written communication to handle otherwise, is strictly prohibited. If you have received this transmission in error, please notify me immediately by email.
On Thursday, June 10, 2021, 9:03:09 AM PDT, Kelly Dunn <kdunn9@jhmi.edu> wrote:
Dear Colleagues,
I am writing with the sad news that Dr. Martin Iguchi, Ph.D., a pillar in our Division and scientific community, passed away on Saturday June 5, 2021. Dr. Iguchi earned his PhD in experimental psychology from Boston University in 1986 and established himself as a major leader in our field over the past several decades. As his CV demonstrates, he led research in several impactful areas that included HIV research, treatment access for minority individuals, and expansion of care for persons with OUD and alcohol. His collective work spanned the spectrum from understanding mechanistic foundations of substance use to treatment implementation. Despite his strong science, Dr. Iguchi may have been equally well-known for being an exemplary scientific citizen. He has served in every capacity, including study sections, committee memberships, board of director and advisory board positions, and editorial roles. He also shared his wisdom through teaching, mentoring numerous junior scientists in predoctoral, post-doctoral, and early career roles, and his service on dissertation and promotion committees, earning awards for his prowess in this area. In recent years he had established himself as a policy leader who could be relied upon to help advocate for the advancement of research and care for persons with substance use disorder, producing a lasting legacy on our field.
Dr. Iguchi was particularly committed to the work of APA and Division 28. He achieved Fellow status of our division in 2000 and was a fellow of Divisions 6, 9, and 50 as well. He was the 2004 Division 28 Convention Chair, Member-at-Large for Division 50, member of the Board of Professional Affairs, member of an APA task force to make changes to the convention that would appeal to scientists, a member of the Board of Scientific Affairs, on the Health Disparities Steering Committee, on the Committee of Psychology of AIDS, and on the Board for the Advancement of Psychology in the Public Practice. As a result of his profound contributions to the field, Dr. Iguchi was awarded an APA Presidential Citation in 2019 (a prestigious honor reserved for only a small number of outstanding psychologists).
Dr. Iguchi was well-known at APA Consolidated Meetings as well as other professional organizational meetings, and always approached people with a smile and kind words. His welcoming demeanor and breadth of expertise made him an ideal ambassador for our science and his veracity in advocating for the use of science to advance public policy no doubt benefited countless numbers of patients and scientists. He represents the type of scientist we all aspire to become and will be dearly missed.
More about his work is available here https://www.rand.org/about/people/i/iguchi_martin_y.html and his APA Presidential citation is available here: https://www.apa.org/about/governance/president/citation/martin-iguchi
Please also see the following thoughts from our Divisional member and past President Dr. Maxine Stitzer
"I first met Martin Iguchi in the late 80's when he worked as a Postdoc at the BPRU on studies conducted in our methadone research clinic. Over the years, he became a friend as well as a valued colleague and he will be sorely missed in both roles. Martin was enthusiastic, passionate, and optimistic about life. He was diagnosed with metastatic colon cancer 5 years ago, and at that time, given a prognosis of one year. He looked at the life he loved and chose to forge ahead. He loved his work in addictions research and he loved his wife, Beth and their children Benjamin and Sarah. He chose to pursue his research projects vigorously until he physically could no longer, contributing his wisdom to the important public health issues of the day and the research that underpins sensible policy.
Maybe it was his positive attitude- these things are unknowable- but Martin beat the odds and stayed in this world, fighting his disease, for 5 long years after that first bleak prognosis. We called him the "medical miracle". In the end, of course, the cancer won. But Martin's attitude was truly admirable. He accepted his diagnosis and was forthright with friends about the process of the illness and its treatment, all the while continuing to work and to enjoy his life.
Meanwhile, Beth was beside him offering her support. They were a team, Martin and Beth, and I know it's hard for her to imagine her life without him. Because I grew up in Los Angeles where Duncan and I visited frequently, we would always stop to see Martin and Beth in Santa Monica and bask in their gracious hospitality. Nothing fancy mind you, but they were always pleased to see us and to share a meal in the house or the backyard. I have a fond memory of taking my elderly mother with us on one or two of these visits and seeing her entertained by Martin and Beth's friendly company. Our world will be a lesser place without Martin; we will greatly miss his enthusiasm, energy, passion, wisdom and friendship. Farewell, dear friend and colleague."- Dr. Maxine Stitzer
---
Kelly Dunn, Ph.D., M.B.A.
Kelly Dunn, Ph.D., M.B.A.
President, Division on Psychopharmacology and Substance Use (Division 28)
American Psychological Association
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030
_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28
Subscribe to:
Posts (Atom)